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Abstract
Background: Xenotropic Murine Leukemia Virus-related (XMRV) virus is a recently identified mouse
gammaretrovirus that has the ability to infect certain human cells. In this study, we investigated the susceptibility
of primary neuronal cell types to infection with XMRV.
Findings: We observed that the human primary progenitors, progenitor-derived neurons, and progenitor-derived
astrocytes supported XMRV multiplication. Interestingly, both progenitors and progenitor-derived neurons were
more susceptible compared with progenitor-derived astrocytes. In addition, XMRV-infected Jurkat cells were able to
transmit infection to neuronal cells.
Conclusions: These data suggest that neuronal cells are susceptible for XMRV infection.
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Findings
XMRV has been associated with prostate cancer and
CFS [1,2]. Although CFS patients show many symptoms
for inflammation in brain, there is no report about the
presence of XMRV in the brain of CFS patients. In an
effort to determine the susceptibility of neuronal cells to
XMRV in-vitro, we used human primary Progenitors,
Progenitor-Derived Neurons (PDN), and Progenitor-
Derived Astrocytes (PDA). Human central nervous sys-
tem progenitor cells were isolated from an 8-week-
gestation fetal brain according to National Institutes of
Health guidelines. The isolation and culture conditions
of the progenitor cells and subsequent selective differen-
tiation into neurons were previously reported [3]. Pro-
genitor cultures stained positive for nestin staining
(Figure 1A). Differentiation of progenitors into an astro-
cytic lineage PDA was initiated by growing the cells in
Eagle minimal essential medium supplemented with
10% fetal bovine serum (Quality Biologicals, Gaithers-
burg, MD) (Figure 1B). Progenitors were differentiated
into a neuronal phenotype (MAP-2+, bIII-tubulin+, and
negative for nestin) by culturing in 10 ng/ml brain-
derived neurotrophic factor and 10 ng/ml platelet-
derived growth factor A/B (Sigma, St. Louis, Mo.) (Fig-
ure 1C).
XMRV (10
8 copies/mL) was used to infect progeni-
t o r s ,P D N ,a n dP D Af o rt w oh o u r s ,a n dt h e nw a s h e d ,
replenished with appropriate fresh neuronal media. Four
days after the infection, cells were washed four times,
and harvested for total RNA isolation. Real-time quanti-
tative PCR was performed with Master Mix (Quantitect
Probe RT-PCR, Qiagen) using forward and reverse pri-
mers encoding gag region of XMRV, probe, RT-mix,
and 1 ug of RNA in a total volume of 25 uL. The mix-
ture was incubated at 50°C for 20 min, at 95°C for 10
min, and then cycled at 95°C for 15 sec and 60°C for 60
sec 40 times, using the Applied Biosystems 7500
sequence detection system. XMRV levels were quanti-
tated using the XMRV clone VP62-pcDNA3.1 (GenBank
accession no. EF185282; obtained through NIH AIDS
Research and Reference Reagent Program) as a standard.
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ceraldehyde-3-phosphate dehydrogenase (GAPDH) RNA
expression.
As shown in Figure 2A., four days post-infection, PDN
showed higher susceptibility to XMRV infection, having
a b o u t9 0p go fX M R VR N A / u go ft o t a lc e l l u l a rR N A .
The infected progenitors contained about 50 pg of
XMRV RNA/ug of total cellular RNA. Interestingly,
infected PDA had levels around 7 pg of XMRV RNA/ug
of total cellular RNA. We also measured XMRV levels
in the culture media, and found a similar trend (results
not shown).
To compare the infectivity of XMRV in neuronal cells
with non-neuronal cell types, the average XMRV levels
measured four days post-XMRV infection in various cell
types are presented in Table 1. Of many cell types tested
for the XMRV infectivity, we observed maximal infectiv-
ity in LNCaP cells. This is in agreement with reported
studies that the human prostate adenocarcinoma cell
line LNCaP which provides optimal environment for the
XMRV multiplication. Interestingly, the neuronal cells
showed high susceptibility to XMRV compared with
another human prostate carcinoma cell line DU145.
T-cell traffic into the central nervous system is
thought to occur when activated T-cells cross the
blood-brain barrier [4]. The T-cells presumably act as a
“Trojan horse” to store and transport infectious
materials across the blood-brain barrier. This “Trojan
horse” hypothesis has been well established in the
pathogenesis of many viruses that infect the central ner-
vous system [5-7]. Based on the assumption that XMRV
infected lymphocytes could infiltrate and infect the neu-
ronal cells, we conducted an in-vitro co-infection/co-
culture study using XMRV-infected Jurkat cells with
neuronal cells.
To produce XMRV-infected Jurkat cells, Jurkat cells
were exposed with XMRV (1.0 × 10
8 copies of XMRV/
mL) for two hours, washed and replenished with fresh
media. Four weeks after the infection, cells were
washed four times, and harvested for total RNA isola-
tion. The XMRV levels were measured using Real-time
PCR method as described above. The XMRV-infected
Jurkat cells had levels around 500 pg of XMRV per ug
of total RNA. For the co-infection/co-culture experi-
ment, 1.0 × 10
6 XMRV-infected Jurkat cells (XMRV
equivalent of 500 pg) were pelleted, treated with tryp-
sin for 3 min at room temperature, washed and sus-
pended in progenitor/PDN/PDA media; and added on
to the appropriate adherent neuronal cell types (pro-
g e n i t o r s ,P D N ,o rP D A )g r o w ni n2 4w e l lp l a t e( 2 . 5×
10
5 cells/well). Four hours after co-infection/co-cul-
ture, XMRV-infected Jurkat cells were removed, and
the adherent neuronal cells were washed with appro-
priate neuronal media. To remove any adhered Jurkat
cells from neuronal cells, each culture well was treated
with trypsin, and just before the cells were ready to
detach (after about 3 min), fresh neuronal media were
added and washed three times using neuronal media.
The resulting adherent neuronal cells were free from
Jurkat cells, and continued to grow with appropriate
neuronal media. After four days, the neuronal cells
were harvested for total RNA isolation, and XMRV
levels were quantified.
As in the neuronal infection study (Figure 2A), the co-
culture/co-infection of XMRV-infected Jurkat (XMRV
equivalent of 500 pg) with neuronal cells resulted in
proportionate XMRV infection in neuronal cells (Figure
2B). In a separate co-culture/co-infection experiment,
the XMRV-infected Jurkats (XMRV equivalent of 4.8
pg) were added with individual neuronal cells (progeni-
tor, PDN, or PDA) as described above, continued for
four days. We observed that even the small amount of
XMRV in the XMRV-infected Jurkats could release
virus and infect the neuronal cells (results not shown).
Interestingly, in the co-cultures/co-infection study, we
co-culture the XMRV-infected Jurkats with neuronal
cells only for four hours. The released virus during this
time was able to infect the bystander neuronal cells.
These observations support the possibility that the infil-
trated XMRV-infected T-cells could infect neuronal
cells.
A B
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Figure 1 Human neuronal cells used for the XMRV infection
study: A. Human neural progenitor cells (NPCs) generated from a
human fetal brain. Progenitor cells were labeled with human nestin-
specific goat anti-mouse FITC (green) monoclonal antibody
(Invitrogen, A10530). Nuclei were stained with DAPI. B. Progenitor-
derived Astrocyte (PDA). PDAs express GFAP. Cells were stained
using donkey anti-rabbit IgG-TRITC (orange) secondary antibody
(Jackson ImmunoRes, 711-025-152). Nuclei are shown in blue (DAPI).
C. Progenitor-derived neurons (PDN). PDNs express the neuron-
specific class III b-tubulin (TUJ1) marker. Cells were stained using
goat anti-mouse Alexa Fluor 647 (Red) secondary antibody
(Invitrogen: A21241). Nuclei were stained with DAPI (blue).
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Page 2 of 4Brain cells are protected from pathogens by the blood-
brain barrier. Even though neuronal cells are susceptible
f o rX M R Vi n f e c t i o n ,t h i sv i r u ss h o u l df i r s tc r o s st h e
blood-brain barrier to inflict any damage to the brain
cells in vivo. After XMRV is transported to neuronal
cells, the virus needs favorable multiplication environ-
ment for its multiplication. For example, we have
observed the requirement of nuclear factor I-A (NF-IA)
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Figure 2 Infection of XMRV in Primary Neuronal cell types. A. Progenitors, PDNs, or PDAs are plated on 24-well poly d-lysine coated plates
(2.5 × 10
5 cells/well). XMRV (10
7 copies/mL) was exposed these cells for two hours. Four days post-infection, XMRV levels were measured from
the total RNA. Results are from three independent experiments. B. Infection of XMRV on Neuronal Cells Co-cultured with XMRV-infected Jurkat
cells. XMRV-infected Jurkat cells are exposed on the adherent neuronal cells for four hours. The Jurkat cells were washed and the XMRV from the
neuronal cells were measured. Results are from three independent experiments.
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Page 3 of 4for the XMRV multiplication in Jurkat cells (unpub-
lished observation). Interestingly, both progenitors and
neurons express higher levels of NF-IA [8], and this
could account for the optimal XMRV multiplication in
these cells. In addition, PDA, which is shown to express
low NF-IA level compared to progenitor and PDN [8],
showed lower susceptibility to XMRV.
In a recent animal study, XMRV was administered to
rhesus macaques through intravenous inoculation [9].
Interestingly, 291 days post-infection, infected cells were
detectable by fluorescence in situ hybridization (FISH)
in brain, showing the possibility of XMRV infection in
the brain. This study further substantiates our specula-
tion that XMRV could infect brain cells. Further in-vitro
and in-vivo studies are warranted to identify and charac-
terize the XMRV, and its role if any, in the brain cells.
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Table 1 Comparison of XMRV infection
Cell Type XMRV level (pg/ug total RNA)
Progenitor Primary neuronal 50.0
Progenitor-derived Neuron Primary neuronal 90.0
Progenitor-derived Astrocyte Primary neuronal 7.2
Jurkat Immortalized T-cell 4.8
DU145 Human prostate carcinoma 3.8
LNCaP Human prostate adenocarcinoma 516
293T Human embryonic kidney 0.158
Neuronal and non-neuronal cells were exposed with XMRV (10
7 copies/mL) for two hours. Four days post-infection, XMRV levels were measured from the total
RNA.
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